SEARCH

SEARCH BY CITATION

References

  • 1
    Valentin L. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal origin. Eur J Obstet Gynecol 1997; 72: 6372.
  • 2
    Valentin L. Use of morphology to characterize and manage common adnexal masses. Best Pract Res Clin Obstet Gynaecol 2004; 18: 7189.
  • 3
    Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I; International Ovarian Tumor Analysis (IOTA) Group. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500505.
  • 4
    Valentin L, Ameye L, Testa A, Lécuru F, Bernard JP, Paladini D, Van Huffel S, Timmerman D. Ultrasound characteristics of different types of adnexal malignancies. Gynecol Oncol 2006; 102: 4148.
  • 5
    Valentin L, Ameye L, Jurkovic D, Metzger U, Lécuru F, Van Huffel S, Timmerman D. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol 2006; 27: 438444.
  • 6
    Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Van Calster B, Collins WP, Vergote I, Huffel SV, Valentin L. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: A multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005; 23: 87948801.
  • 7
    Marret H, Sauget S, Giraudeau B, Body G, Tranquart F. Power Doppler vascularity index for predicting malignancy of adnexal masses. Ultrasound Obstet Gynecol 2005; 25: 508513.
  • 8
    Suren A, Osmers R, Kulenkampff D, Kuhn W. Visualization of blood flow in small ovarian tumor vessels by transvaginal color Doppler sonography after echo enhancement with injection of Levovist. Gynecol Obstet Invest 1994; 38: 210212.
  • 9
    Marret H, Sauget S, Giraudeau B, Brewer M, Ranger-Moore J, Body G, Tranquart F. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J Ultrasound Med 2004; 23: 16291639.
  • 10
    Emoto M, Fujimitsu R, Hiwasaki H, Kawarabayashi T. Normal sized ovarian cancer detected by colour Doppler ultrasound using a microbubble contrast agent. J Clin Oncol 2003; 21: 37033705.
  • 11
    Ordén MR, Gudmundsson S, Kirkinen P. Contrast-enhanced sonography in the examination of benign and malignant adnexal masses. J Ultrasound Med 2000; 19: 783788.
  • 12
    Cotter B, Mahamud E, Kwan OL. New ultrasound contrast agents: expanding upon existing clinical applications. In Ultrasound Contrast Agents, GoldbergB (ed). Martin Dunitz Ltd: London, 1997; 3142.
  • 13
    Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA, Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000; 35: 8085.
  • 14
    Bokor D, Chambers JB, Rees PJ, Mant TGK, Luzzani F, Spinazzi A. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 2001; 36: 104109.
  • 15
    Testa AC, Ferrandina G, Fruscella E, Van Holsbeke C, Ferrazzi E, Leone FP, Arduini D, Exacoustos C, Bokor D, Scambia G, Timmerman D. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study. J Ultrasound Med 2005; 24: 12671278.